首页> Frontiers in microbiology> Serum interleukin-6, procalcitonin, and C-reactive protein at hospital admission can identify patients at low risk for severe COVID-19 progression.

Serum interleukin-6, procalcitonin, and C-reactive protein at hospital admission can identify patients at low risk for severe COVID-19 progression.

导出 LinkOut

翻译打印收藏纠错

第一作者： Christian Matthias,Zobel

第一单位： Department of Internal Medicine, Bundeswehr Hospital, Berlin, Germany.

作者： Christian Matthias,Zobel ^[1] ; Werner,Wenzel ^[2] ; Jan Philipp,Krüger ^[2] ; Ulrich,Baumgarten ^[1] ; Tobias,Wagelöhner ^[1] ; Nino,Neumann ^[1] ; Behruz,Foroutan ^[1] ; Rico,Müller ^[3] ; Annette,Müller ^[3] ; Dominic,Rauschning ^[4] ; Meike,Schüßler ^[4] ; Lorenz,Scheit ^[5] ; Felix,Weinreich ^[5] ; Klaas,Oltmanns ^[6] ; Franziska,Keidel ^[6] ; Maria,Koch ^[6] ; Sebastian,Spethmann ^[7] ; Maximilian,Schreiner ^[8]

作者单位： Department of Internal Medicine, Bundeswehr Hospital, Berlin, Germany. ^[1] Department of Microbiology and Hospital Hygiene, Bundeswehr Hospital, Berlin, Germany. ^[2] Department of Laboratory Medicine, Bundeswehr Hospital, Berlin, Germany. ^[3] Department of Internal Medicine, Bundeswehr Central Hospital, Koblenz, Germany. ^[4] Department of Internal Medicine, Bundeswehr Hospital, Hamburg, Germany. ^[5] Department of Internal Medicine, Bundeswehr Hospital, Westerstede, Germany. ^[6] Department of Cardiology, Angiology and Intensive Care Medicine ^[7] CCM, Deutsches Herzzentrum der Charité - Medical Heart Center of Charité and German Heart Institute Berlin, Berlin, Germany.;Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. ^[8]

关键词 ARDS SARS-CoV-2 cytokine release syndrome mechanical ventilation neopterin

DOI 10.3389/fmicb.2023.1256210

PMID 37937220

发布时间 2023-11-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交